Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302) - Université de Bourgogne Accéder directement au contenu
Article Dans Une Revue Clinical Colorectal Cancer Année : 2020

Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)

Fichier non déposé

Dates et versions

hal-03284418 , version 1 (12-07-2021)

Identifiants

Citer

Alexandra Lapeyre-Prost, Simon Pernot, Julie Sigrand, Karine Le Malicot, Florence Mary, et al.. Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302). Clinical Colorectal Cancer, 2020, 19 (4), pp.285-290. ⟨10.1016/j.clcc.2020.06.003⟩. ⟨hal-03284418⟩
28 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More